Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2021

Apr 6, 2021

33625_dirs_2021-04-05_28123936-98b1-486c-b851-85b1e3eccc64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-01

Reporting Person: Shabshab Nabil (Director, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Restricted Stock Unit $ A 33872 Acquired Common Stock (33872) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2: Originally filed Form 4 reported 16,936.

F3: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2023, and the remaining 50% of the
restricted stock units will vest in 1/8th quarterly installments over the following 2 years.

F4: Originally filed form 4 reported incorrect vesting schedule.